Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users

Psychopharmacology

Volumn 207, Issue 4, 2010, Pages 583-591

  Schilt, Thelma ^a   Koeter, Maarten W J ^a   Smal, Johan P ^a   Gouwetor, Mathilde N ^a   Van Den Brink, Wim ^a   Schmand, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Ageing; Ecstasy; MDMA; Memory; Neuropsychology

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; AGE; AGED; ARTICLE; ATTENTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DEPTH PERCEPTION; FEMALE; HUMAN; IMPULSIVENESS; MALE; MEMORY DISORDER; MULTIPLE DRUG ABUSE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PRIORITY JOURNAL; SELF CONCEPT; VERBAL MEMORY; VISUAL MEMORY;

ADULT; AGE FACTORS; ATTENTION; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HALLUCINOGENS; HUMANS; IMPULSIVE BEHAVIOR; MALE; MEMORY DISORDERS; MIDDLE AGED; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; VERBAL LEARNING;

EID: 72049113318     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1688-z     Document Type: Article

References (45)

1. Beck AT, Steer RA (1984) Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40:1365-1367
2. Beck AT, Ward CH, Mendelsohn M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
3. Benton AL, Varney NR, Hamsher KD (1978) Visuospatial judgment. A clinical test. Arch Neurol 35:364-367
4. Bouman TK, Kok AR (1987) Homogeneity of Beck's Depression Inventory (BDI): applying Rasch analysis in conceptual exploration. Acta Psychiatr Scand 76:568-573
5. Cools R, Roberts AC, Robbins TW (2008) Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci 12:31-40 (Pubitemid 50012215)
6. de Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, den Heeten GJ, Ramsey NF, Korf DJ, van den Brink W (2005) The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. Int J Methods Psychiatr Res 14:167-185 (Pubitemid 43013585)
7. Feij JA, van Zuilen RW (1984) Handleiding bij de spanningsbehoeftelijst (SBL). Swets & Zeitlinger, Lisse
8. Feij JA, van Zuilen RW, Gazendam A (1982) De ontwikkeling van een Nederlandse vragenlijst voor sensation seeking: de spanningsbehoeftelijst (SBL). Gedrag 10:364-383
9. Fox HC, Parrott AC, Turner JJ (2001) Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. J Psychopharmacol 15:273-281
10. Garcia-Alloza M, Gil-Bea FJ, ez-Ariza M, Chen CP, Francis PT, Lasheras B, Ramirez MJ (2005) Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia 442:442-449 (Pubitemid 40222131)
11. Goldberg S, Smith GS, Barnes A, Ma Y, Kramer E, Robeson K, Kirshner M, Pollock BG, Eidelberg D (2004) Serotonin modulation of cerebral glucose metabolism in normal aging. Neurobiol. Aging 25:167-174 (Pubitemid 38121690)
12. Gouzoulis-Mayfrank E, Daumann J (2006a) Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction 101:348-361
13. Gouzoulis-Mayfrank E, Daumann J (2006b) The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol 20:188-193
14. Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J (2003) Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Prog Neuropsychopharmacol Biol Psychiatry 27:819-827 (Pubitemid 36966764)
15. Graham FK, Kendall BS (1960) Memory-for-design: revised general manual. Percept Motor Skills 11:147-188
16. Gronwall DM (1977) Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44:367-373
17. Guillot C (2007) Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms? J Psychoactive Drugs 39:31-39
18. Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic, Orlando
19. Kalechstein AD, De La GR, Mahoney JJ III, Fantegrossi WE, Newton TF (2007) MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl) 189:531-537 (Pubitemid 44791222)
20. Lai MK, Tsang SW, Alder JT, Keene J, Hope T, Esiri MM, Francis PT, Chen CP (2005) Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease. Psychopharmacology (Berl) 179:673-677 (Pubitemid 40674769)
21. Laws KR, Kokkalis J (2007) Ecstasy (MDMA) and memory function: a meta-analytic update. Hum Psychopharmacol 22:381-388 (Pubitemid 47316122)
22. Lundqvist T (2005) Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology Biochemistry and Behavior 81:319-330
23. McEntee WJ, Crook TH (1991) Serotonin, memory, and the aging brain. Psychopharmacology (Berl) 103:143-149
24. Meltzer CC, Smith G, DeKosky ST, Pollock BG, Mathis CA, Moore RY, Kupfer DJ, Reynolds CF III (1998) Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 18:407-430 (Pubitemid 28202350)
25. Meneses A (1999) 5-HT system and cognition. Neurosci Biobehav Rev 23:1111-1125
26. Munro CA, Saxton J, Butters MA (2000) The neuropsychological consequences of abstinence among older alcoholics: a cross-sectional study. Alcohol Clin Exp Res 24:1510-1516 (Pubitemid 30794345)
27. Netter P, Hennig J, Roed IS (1996) Serotonin and dopamine as mediators of sensation seeking behavior. Neuropsychobiology 34:155-165 (Pubitemid 26355760)
28. Parrott AC (2006) MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol 20:147-163
29. Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 51:768-774
30. Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M (2006) Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction. J Psychopharmacol 20:373-384
31. Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J (2001) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Arch Gen Psychiatry 58:901-906 (Pubitemid 32937910)
32. Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ (2006) Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol 20:164-175
33. Rey A (1964) L'examen clinique en psychologie. Presses Universitaires de France, Paris
34. Richter-Levin G, Segal M (1996) Serotonin, aging and cognitive functions of the hippocampus. Rev Neurosci 7:103-113 (Pubitemid 26232248)
35. Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B (2007) Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry 64:728-736 (Pubitemid 46878673)
36. Schilt T, de Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W (2008) Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychol Med 38:1309-1317
37. Schilt T, Koeter MW, de Win MM, Zinkstok JR, van Amelsvoort TA, Schmand B, den BW (2009) The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene. Eur Neuropsychopharmacol 19:116-124
38. Schmand B, Bakker D, Saan R, Louman J (1991) The Dutch Reading Test for Adults: a measure of premorbid intelligence level. Tijdschr Gerontol Geriatr 22:15-19
39. Shepard RN, Metzler J (1971) Mental rotation of three-dimensional objects. Science 171:701-703
40. Trimbos-instituut, Utrecht (2005) Nationale Drug Monitor. Jaarbericht 2005
41. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J (2005) Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc 11:290-302
42. Verbaten MN (2003) Specific memory deficits in ecstasy users? The results of a meta-analysis. Hum Psychopharmacol 18:281-290
43. Wechsler D (1981) WAIS-R manual. The Psychological Corporation, San Antonio
44. Zuckerman M (1994) Behavioral expressions and biosocial bases of sensation seeking. Cambridge University Press, Cambridge
45. Zuckerman M, Link K (1968) Construct validity for the sensation-seeking scale. J Consult Clin Psychol 32:420-426